Through their kind and generous support, we are able to provide the Vision Atlas as a free knowledge resource for eye health. If your organisation would like to find out more about our sponsor opportunities please contact Nick Parker, Head of Commercial Development at IAPB, for more information.
Allergan plc, headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, the company’s R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. This approach has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programmes in development.
With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth.
Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion.
CBM is one of the leading international development agencies for people with disabilities. It supports the provision of services to persons with visual, hearing and physical impairment in more than 113 developing countries. CBM assists persons with disabilities regardless of their nationality, gender, or religion.
CBM supports its partners in implementing the projects financially and by seconding qualified employees such as ophthalmologists and orthopaedic surgeons, administrators and CBR experts whose foremost task is to train national specialists. Helping others to help themselves is the most promising way to enable developing countries to gradually become independent of foreign aid.
The Fred Hollows Foundation is a leading international development organisation that has restored sight to more than 2.5 million people around the world and has supported programs to deliver more than 100 million doses of antibiotics for trachoma.
The Foundation’s vision is for a world where no person is needlessly blind or vision impaired. It continues the work of the late Professor Fred Hollows, a globally-renowned eye surgeon who believed everyone should have access to high-quality affordable eye care no matter where they live. The Foundation works in more than 25 countries throughout Africa, South Asia and the Middle East, South East Asia and the Pacific. Its work is focussed on strengthening health systems and empowering local people to deliver local eye health solutions.
Seva Foundation is a global nonprofit eye care organization that works with local communities around the world to develop self-sustaining programs that preserve and restore sight. Seva works with partners in more than 20 countries including the US.
Sightsavers aims to prevent avoidable blindness and support the inclusion of people with disabilities across the world’s poorest regions.
Sightsavers works in more than 30 countries and provide eye operations for people who need them, train eye care workers and surgeons to provide sight-saving treatment, and help people with disabilities to live independent lives. Through community volunteers, we also distribute medication to protect people from blinding diseases.
In all our health work we advocate for universal health coverage for everyone, meaning all people, wherever they live, can access quality, affordable health care. To this end, we work with stakeholders to ensure all eye health is sustainable, accessible and planned with gender and disability considerations in mind.